These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 8150413

  • 21. Nuclear imaging techniques for the assessment of myocardial viability.
    Jain D, Zaret BL.
    Cardiol Clin; 1995 Feb; 13(1):43-57. PubMed ID: 7796431
    [Abstract] [Full Text] [Related]

  • 22. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G, Schwaiger M.
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract] [Full Text] [Related]

  • 23. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR.
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [Abstract] [Full Text] [Related]

  • 24. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
    Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T.
    J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
    [Abstract] [Full Text] [Related]

  • 25. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y, Senda M, Torizuka K.
    J Cardiol Suppl; 1987 Apr; 15():65-9. PubMed ID: 3509973
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J.
    J Cardiol; 1992 Apr; 22(2-3):283-93. PubMed ID: 1339787
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P, Brandt-Mainz K, Freudenberg L, Vogt FM, Neumann T, Knipp S, Barkhausen J.
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Positron emission tomography in cardiovascular disease.
    Beanlands R.
    Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
    [Abstract] [Full Text] [Related]

  • 32. [Cardiologic applications of positron emission tomography].
    Schelbert H, Czernin J.
    Wien Klin Wochenschr; 1994 Oct; 106(15):487-95. PubMed ID: 7941597
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
    de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A.
    Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.
    Schulz G, von Dahl J, Kaiser HJ, Koch KC, Sabri O, Banneitz L, Cremerius U, Buell U.
    Nucl Med Commun; 1996 Dec; 17(12):1057-64. PubMed ID: 9004303
    [Abstract] [Full Text] [Related]

  • 38. Metabolism and blood flow as new markers of myocardial viability in the evolution of myocardial infarction.
    Schwaiger M.
    Eur J Nucl Med; 1986 Dec; 12 Suppl():S62-5. PubMed ID: 3490380
    [Abstract] [Full Text] [Related]

  • 39. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
    Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J.
    Circulation; 1995 Dec 15; 92(12):3436-44. PubMed ID: 8521565
    [Abstract] [Full Text] [Related]

  • 40. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
    Knapp WH.
    Nuklearmedizin; 1995 Jun 15; 34(3):118-26. PubMed ID: 7630745
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.